Baker Hughes Co (BKR) concluded trading on Wednesday at a closing price of $46.89, with 5.06 million shares of worth about $237.06 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 34.20% during that period and on February 19, 2025 the price saw a loss of about -0.19%. Currently the company’s common shares owned by public are about 989.65M shares, out of which, 988.46M shares are available for trading.
Stock saw a price change of -0.47% in past 5 days and over the past one month there was a price change of 0.75%. Year-to-date (YTD), BKR shares are showing a performance of 14.31% which increased to 60.58% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $28.66 but also hit the highest price of $49.40 during that period. The average intraday trading volume for Baker Hughes Co shares is 6.82 million. The stock is currently trading 1.67% above its 20-day simple moving average (SMA20), while that difference is up 6.74% for SMA50 and it goes to 23.56% higher than SMA200.
Baker Hughes Co (NASDAQ: BKR) currently have 989.65M outstanding shares and institutions hold larger chunk of about 94.36% of that.
The stock has a current market capitalization of $46.43B and its 3Y-monthly beta is at 1.28. PE ratio of stock for trailing 12 months is 15.74, while it has posted earnings per share of $2.98 in the same period. Its PEG reads 1.26 and has Quick Ratio of 0.94 while making debt-to-equity ratio of 0.40. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BKR, volatility over the week remained 1.85% while standing at 2.68% over the month.
Stock’s fiscal year EPS is expected to rise by 10.08% while it is estimated to increase by 15.68% in next year. EPS is likely to shrink at an annualized rate of 12.47% for next 5-years, compared to annual growth of 66.90% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on December 19, 2024 offering an Overweight rating for the stock and assigned a target price of $53 to it. On September 25, 2024, Wells Fargo Upgrade their recommendations, while on July 29, 2024, TD Cowen Reiterated their ratings for the stock with a price target of $50. Stock get a Peer perform rating from Wolfe Research on January 29, 2024.